Pre-dementia cognitive impairment

Cognitive disorders are one of the most significant problems of older. Special attention should be paid to the diagnosis of early pre-dementia stages of cognitive impairment (CI): subjective, subtle and mild.
The aim of this study was to determine the criteria of pre-mild: subjective and subtle cognitive decline (SCD).
Material and methods. The study included 602 patients with pre-mild cognitive impairment with a mean age of 63.24±11.24 years and 515 patients with mild cognitive impairment aged 71.2±8.0 years. The indicators of patients were compared with those of 104 healthy people (average age 64.23±8.14 years) who did not complain of memory impairment and had no deviations during clinical and neuropsychological examination.
Results and discussion. Groups of patients with subjective and subtle cognitive decline were distinguished, which differed in most characteristics. At the same time, in both groups of patients, deviations in the results of neuropsychological tests did not exceed one standard deviation from the average results for healthy people, which, in fact, allowed them to be attributed to «pre-mild» cognitive decline. The data obtained confirmed the heterogeneity of the «pre-mild» cognitive decline. The study also shows the allocation limitation of pre-mild cognitive impairment only on the basis of a formal approach based on the quantitative characteristics of neuropsychological research with a difference from control groups necessarily exceeding one standard deviation.
Conclusion. The analysis showed the heterogeneity of pre-dementia and pre-mild cognitive impairments that are divided according to the degree of changes in objectively assessed cognitive functions with the similarity of subjective complaints. It is proposed to distinguish subjective cognitive decline with completely normal neuropsychological characteristics and subtle cognitive decline in the event of changes in individual indicators evaluating mainly the control functions and memory.

1. Amariglio R.E., Becker J.A., Carmasin J. et al. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia. 2012 Oct; 50(12): 2880–2886. DOI: 10.1016/j.neuropsychologia.2012.08.011.

2. Amieva H., Le Goff M., Millet X. et al.. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol. 2008 Nov; 64(5): 492–8. DOI: 10.1002/ana.21509.

3. Caracciolo B., Gatz M., Xu W. et al. Differential distribution of subjective and objective cognitive impairment in the population: a nation-wide twin-study. J Alzheimers Dis. 2012; 29(2): 393–403. DOI: 10.3233/JAD-2011–111904.

4. Dufouil C., Fuhrer R., Alpérovitch A. Subjective cognitive complaints and cognitive decline: consequence or predictor? The epidemiology of vascular aging study. J Am Geriatr Soc. 2005 Apr; 53(4): 616–21. DOI: 10.1111/j.1532–5415.2005.53209.x.

5. Zaharov VV, Yаhno NN. Sindrom umerennyh kognitivnyh narushenij v pozhilom vozraste — diagnostika i lechenie. Russkij medicinskij zhurnal 2004; 10: 573 –6. (In Russ).

6. Lokshina AB, Zaharov VV. Lyogkie i umerennye kognitivnye rasstrojstva pri discirkulyatornoj encefalopatii. // Nevrologicheskij zhurnal. — 2006. — T.11. –Prilozhenie № 1. — S. 57–63. (In Russ).

7. Cheng Y.W., Chen T.F., Chiu M.J. From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution. Neuropsychiatr Dis Treat. 2017 Feb 16; 13: 491–498. DOI: 10.2147/NDT.S123428.

8. Zaharov VV. Kognitivnye rasstrojstva bez demencii: klassifikaciya, osnovnye prichiny i lechenie. Effektivnaya farmakoterapiya. Nevrologiya №1 (1) — 2016. S. 22–30. (In Russ).

9. Zakharov V.V. Evolution of cognitive deficit: mild and moderate cognitive impairments. Neurology, Neuropsychiatry, Psychosomatics. 2012; 4(2): 16–21. https://doi.org/10.14412/2074-2711-2012-376. (In Russ.)

10. Yаhno NN. Kognitivnye rasstrojstva v nevrologicheskoj klinike. //Nevrologicheskij zhurnal. — 2005. — T.11. — Prilozhenie № 1. — S. 4–12. (In Russ).

11. Jessen F., Amariglio R.E., van Boxtel M. et al. Subjective Cognitive Decline Initiative (SCD-I) Working Group. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014 Nov; 10(6): 844–52. DOI: 10.1016/j.jalz.2014.01.001.

12. Yakhno NN, Zakharov VV, Koberskaya NN. et al. “Pre-moderate”(subjective and light) cognitive disorders. Nevrologichesky Zhurnal, 2017; 22 (4): 198–204. DOI: 10.18821/1560-9545-2017-22-4-198-204. (In Russ).

13. Reisberg B., Shulman M.B., Torossian C. et al. Outcome over seven years of healthy adults with and without subjective cognitive impairment. Alzheimers Dement. 2010 Jan; 6(1): 11–24. DOI: 10.1016/j.jalz.2009.10.002.

14. Edmonds E.C., Delano-Wood L., Galasko D.R. et al. Alzheimer’s Disease Neuroimaging Initiative. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease. J Alzheimers Dis. 2015; 47(1): 231–42. DOI: 10.3233/JAD-150128.

15. Perrotin A., Mormino E.C., Madison C.M. et al. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Arch Neurol. 2012 Feb; 69(2): 223–9. DOI: 10.1001/archneurol.2011.666.

16. Grambaite R., Hessen E., Auning E. et al. Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers. Dement Geriatr Cogn Dis Extra. 2013 Sep 11; 3(1): 291–300. DOI: 10.1159/000354188.

17. Yаhno NN, Koberskaya NN, Zaharov VV. i dr. Vliyanie vozrastnyh, gendernyh, komorbidnyh, serdechno-sosudistyh i emocional'nyh faktorov na sub"ektivnoe kognitivnoe snizhenie.// Nevrol. zhurnal. — 2018 № 4, tom 23 s. 184–190 DOI: 10.18821/1560-9545-2018-23-4-184-189. (In Russ).

18. Yаhno NN, Koberskaya NN, Zaharov VV i dr.Vliyanie vozrasta, komorbidnyh serdechno-sosudistyh i emocional'nyh faktorov na legkoe kognitivnoe snizhenie v srednem, pozhilom i starcheskom vozraste. // Nevrologicheskij zhurnal 2018; 23 (6): 309–315. DOI: 10.18821/1560-9545-2018-23-6-309-315. (In Russ).

19. Hohman T.J., Beason-Held L.L., Lamar M., Resnick S.M. Subjective cognitive complaints and longitudinal changes in memory and brain function. Neuropsychology. 2011 Jan; 25(1): 125–30. DOI: 10.1037/a0020859.

20. Reiman E.M., Langbaum J.B., Tariot P.N. Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible. Biomark Med. 2010 Feb; 4(1): 3–14. DOI: 10.2217/bmm.09.91.

21. Levin OS, Golubeva LV. Geterogennost' umerennogo kognitivnogo rasstrojstva: diagnosticheskie i terapevticheskie aspekty. Sonsilium medicum 2006; 12: 106–110. (In Russ).

22. Uspenskaya OV, Yаhno NN. Vliyanie memantina na kognitivnye funkcii pacientov s amnesticheskim variantom sindroma umerennyh kognitvinyh rasstrojstv (klinikopsihologicheskoe i nejrohimicheskoe issledovanie). Nevrologicheskij zhurnal 2009; 14(3): 37–40. (In Russ).

23. Yаhno NN, Preobrazhenskaya IS, Zaharov VV i dr. Effektivnost' Akatinola memantina u pacientov s nedementnymi kognitivnymi rasstrojstvami. Rezul'taty mnogocentrovogo klinicheskogo nablyudeniya. Nevrologicheskij zhurnal 2010; 15(2): 52–8. (In Russ).

24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). — Arlington, VA: American Psychiatric Publishing, 2013. — 992 p. DOI:10.1176/appi.books.9780890425596.

25. Zaharov VV, Voznesenskaya TG. Nervno-psihicheskie narusheniya: diagnosticheskie testy 2-e izdanie Moskva MEDprecs-inform, 2013. — 320 s (In Russ).

26. Seo E.H., Kim H., Lee K.H., Choo I.H. Altered Executive Function in Pre-Mild Cognitive Impairment. J Alzheimers Dis. 2016 Oct 4; 54(3): 933–940. DOI: 10.3233/JAD-160052.

27. Toledo J.B., Bjerke M., Chen K. et al. Alzheimer's Disease Neuroimaging Initiative. Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings. Neurology. 2015 Jul 14; 85(2): 144–53. DOI: 10.1212/WNL.0000000000001738.

28. Sperling R.A., Aisen P.S., Beckett L.A. et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May; 7(3): 280–92. DOI: 10.1016/j.jalz.2011.03.003.

29. Rodrigue K.M., Kennedy K.M., Devous M.D. et al. β-Amyloid burden in healthy aging: regional distribution and cognitive consequences. Neurology. 2012 Feb 7; 78(6): 387–95. DOI: 10.1212/WNL.0b013e318245d295.

30. Mitchell A.J., Beaumont H., Ferguson D. et al. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014 Dec; 130(6): 439–51. DOI: 10.1111/acps.12336.